The Food and Drug Administration will soon “unleash a massive framework” for how vaccines are tested and approved.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Asia is witnessing a new COVID-19 wave driven by highly transmissible JN.1 sub-variants like LF.7 and NB.1.8, with cases rising sharply in Singapore, Hong Kong, and Thailand. Though symptoms remain ...

Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.

While the ACIP made six recommendations in April, Kennedy has only endorsed three so far; they outline who can use newly licensed chikungunya vaccines. Three others, related to a new meningococcal ...

In other vaccine news, Health Secretary Robert F. Kennedy Jr. has officially ordered placebo testing on new vaccines, a change that experts claim will be costly and — harkening back to polio vaccine ...

Amid a deluge of cuts to federal spending, the Trump administration has canceled three grants totaling $85.6 million to Santa ...

Novavax Inc. jumped in early trading after US regulators fully approved its Covid vaccine, easing investors’ concerns after ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based covid vaccine produced by pharmaceutical giant Novavax.